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Current zoonotic visceral leishmaniasis (ZVL) control programs in Brazil include the culling of Leishmania
infantum-infected reservoir dogs, a strategy that has failed to prevent a rise of canine and human ZVL cases
over the past decade. One of the main reasons this strategy has failed is because of a long delay between sample
collection, sample analysis, and control implementation. A rapid, sensitive, and specific diagnostic tool would
be highly desirable, because it would allow control interventions to be implemented in situ. We compared an
immunochromatographic dipstick test to enzyme-linked immunosorbent assay (ELISA) and PCR for detecting
L. infantum infections in dogs from an area of ZVL endemicity in Brazil. The dipstick test was shown to have
61 to 75% specificity and 72 to 77% sensitivity, compared to 100% specificity for both ELISA and PCR and 71
to 88% and 51 to 64% sensitivity for ELISA and PCR, respectively. Of the field samples tested, 92 of 175 (53%),
65 of 175 (37%), and 47 of 175 (27%) were positive by dipstick, ELISA, and PCR, respectively. The positive and
negative predictive values for the tested dipstick were 58 to 77% and 75%, respectively. Efforts should be made
to develop a more specific dipstick test for diagnosis of leishmaniasis, because they may ultimately prove more
cost-effective than currently used diagnostic tests when used in mass-screening surveys.
Domestic dogs (Canis familiaris) are established reservoir
hosts of zoonotic visceral leishmaniasis (ZVL) caused by Leish-
mania infantum. Hence, one of the approaches to reduce the
incidence of human ZVL (also known as kala-azar) is to cull
infected dogs. The impact of such dog-culling programs on
incidence of human and canine ZVL has been doubted on both
theoretical and practical grounds (10), and the results of con-
trolled intervention trials are equivocal (3, 9). Despite the
culling of an average of 19,500 dogs per year since 1989, the
incidence of human ZVL in Brazil has increased steadily dur-
ing the same period (26). One of the reasons why such control
campaigns have failed is because of the long delay between
sample collection, sample analysis, and control implementa-
tion (i.e., culling of infected dogs). This delay typically is 30
days long, but can be as long as 80 days, with infected dogs
remaining infectious to sandfly vectors during this period and
transmitting ZVL to susceptible dogs and humans. In a study
in Brazil, it was shown that whereas a standard culling strategy
implemented 80 days postsample collection resulted in only a
9% decrease in dog seroprevalence, culling implemented 7
days postsample collection resulted in a 27% decrease in se-
roprevalence (6). Current diagnostic methods used for Leish-
mania mass-screening surveys (mainly enzyme-linked immu-
nosorbent assay [ELISA], immunofluorescence antibody test,
or direct agglutination test) lack sensitivity or specificity, re-
quire technological expertise and specialized laboratory equip-
ment, and can be labor-intensive and time-consuming. Hence,
a rapid, sensitive and specific diagnostic test would be ex-
tremely valuable in mass-screening surveys and intervention
campaigns, because results could be read immediately and
control measures could be implemented in situ. Implementa-
tion coverage rates would be improved (e.g., dog owners often
hide their dogs from culling personnel), and the control inter-
vention would be more effective.
Immunochromatographic dipstick tests for Leishmania diag-
nosis have recently been developed and are all based on re-
combinant K39 (rK39), a protein predominant in Leishmania
infantum and Leishmania donovani tissue amastigotes (7).
rK39 dipstick tests have been shown to be quite sensitive (re-
ported sensitivities, 67 to 100%) and very specific (reported
specificities, 97 to 100%) when tested on kala-azar patients (5,
8, 13, 25, 30), with results similar to those of rK39-ELISAs (1,
4, 7, 12, 14, 17, 18, 24, 28, 29). Although rK39-ELISAs have
been used to detect ZVL infection in dogs (4, 17, 22, 23, 28),
there are no published reports on the use of the rK39 dipstick
to detect ZVL in dogs.
We report a study in which the sensitivity and specificity of
a commercially available immunochromatographic rK39 dip-
stick test were compared to serological and molecular diagnos-
tic tests (ELISA and PCR) used in canine leishmaniasis diag-
nosis. Epidemiological and control intervention implications
are discussed.
MATERIALS AND METHODS
Sampling. Blood samples (2 to 10 ml) were taken from 148 dogs in the
municipality of Capita˜o Eneas (16°30S, 44°00W), an area of L. infantum en-
demicity in Minas Gerais, Brazil. Twenty-seven dogs were sampled again after 5
months. Samples were taken by venipuncture and put into sterile, EDTA-coated
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10-ml polypropylene tubes and processed 4 to 10 h after collection. The blood
was centrifuged at 800  g for 20 min, and the buffy coat layer and sera were
separated and stored at 20°C. Dog age was estimated by tooth wear and by
interviewing dog owners. The mean age of dogs was 34 months (range, 2 to 180
months); 57 of the dogs sampled were female, and 91 were male. No transmission
of Leishmania (Viannia) spp. or Trypanosoma cruzi was reported in the area.
PCR. DNA from buffy coat samples was extracted by using the DNeasy DNA
extraction kit (Qiagen, Crawley, United Kingdom) according to the manufactur-
er’s protocol. All samples were amplified with L. donovani complex-specific
AJS31 (5-GGGGTTGGTGTAAAATAGGGCC-3) and DBY (5-CCAGTTT
CCCGCCCCGGAG-3) primers according to previously published conditions
(20). Amplification products were analyzed by electrophoresis on 1.5% agarose
gels in 1 TAE buffer (40 mM Tris, 40 mM acetic acid, 1 mM EDTA [pH 8.3]).
To evaluate sample degradation or PCR inhibition, sample DNA was also am-
plified for a canine housekeeping gene, an acidic ribosomal phosphoprotein
fragment, by using primers PO3 (5-GGAGAAGGGGGAGATGTT-3) and
PO5 (5-TCATTGTGGGAGCAGACA-3) (2). When samples did not yield
amplification with PO3 and PO5 primers, they were extracted again, until a
positive amplification was obtained. Each amplification cycle included negative
(no DNA, DNA from uninfected dog) and positive (water-lysate mixtures of
reference strain cultures) controls. PCR-grade H2O was used throughout. To
avoid cross-contamination, separate areas were used for DNA extraction, PCR
sample preparation, and amplification.
Hybridization. Agarose gels were processed by standard procedures—i.e., in
denaturation and neutralization buffer for 20 min each and Southern blotted
onto a nylon membrane (Boehringer Mannheim, Basel, Switzerland)—and DNA
was fixed by UV cross-linking. Membranes were prehybridized at 42°C and
hybridized with a [-32P]ATP-labeled B4RsaB probe (5-GACCTGAAACCCT
GGGTCCTGGGCGT-3) for 8 to 12 h (20) and then washed at 65°C twice for
15 min in 2 SSC (1 SSC is 0.15 M NaCl plus 0.015 M sodium citrate)–0.1%
sodium dodecyl sulfate (SDS) and in 0.1 SSC–0.1% SDS, before being exposed
for autoradiography for 36 and 72 h at 70°C.
ELISA. Log-phase L. donovani promastigotes (MHOM/ET/67/L82) were har-
vested at a concentration of ca. 2.5  109 cells/ml, centrifuged at 5,000 rpm,
washed in phosphate-buffered saline (PBS), and frozen at 20°C. Cells were
freeze-thawed and briefly sonicated. Antigen (105 promastigotes per well) was
added to polysterene microtiter plates (Immunolon 2; Thermo LabSystems,
Ashford, United Kingdom) in 100 l of carbonate coating buffer (pH 9.6) and
incubated overnight at 4°C. Plates were washed three times with PBS and
blocked with 100 l of 2% milk powder per well in coating buffer for 2 h at 37°C.
They were then washed three times with PBS, and serum samples were added at
dilutions of 1/100, 1/400, and 1/800 in 100 l of incubation buffer (PBS–0.05%
Tween 20–2% milk powder) and again incubated for 2 h at 37°C. After washing
six times with PBS–0.05% Tween 20, peroxidase-conjugated, affinity-purified
rabbit anti-dog immunoglobulin G (Sigma, Poole, United Kingdom) was added
at 1/1,500 in 100 l of incubation buffer, and plates were incubated for 2 h at
37°C. Plates were washed six times with PBS–0.05% Tween 20, and then 100 l
of substrate solution (O-phenylenediamine dihydrochloride in phosphate-citrate
buffer [pH 5.5]) was added. The reaction was stopped with 50 l of 2 M H2SO4,
and plates were read at 490 nm in an ELISA plate reader.
ELISA standardization. The method used for ELISA standardization was
performed according to Quinnell et al. (19). Briefly, on each plate, a positive
control serum was titrated twofold from 1/20 to 1/327,680. The positive control
serum was assigned an arbitrary number of units per milliliter (81,920/ml), which
was defined as the reciprocal of the highest dilution at which absorbance was
greater than the mean  3 standard deviations of background (no antibody)
wells. Absorbance was calculated as observed absorbance  mean background
absorbance. A standard line was fitted over the range 1/80 to 1/81,920 to the
positive control absorbance values by log-logit transformation (19). The absor-
bances of the dilutions of the three test sera were expressed as antibody units per
milliliter by using the standard line, from which the test sample’s geometric mean
number of antibody units per milliliter was calculated. Where the dilution curve
for any test serum was noticeably nonparallel to the standard, test sera were
repeated at dilutions of 1/100, 1/720, and 1/4,320. Samples were considered
positive when their antibody level was greater than the arithmetic mean of
antibody units per milliliter  3 standard deviations of negative controls.
Dipstick. The dipstick test (Leishmania RAPYDTEST; Intersep, Wokingham,
United Kingdom) was carried out according to the manufacturer’s instructions.
The dipsticks were briefly placed into 50 l of serum. After 5 to 8 min, a red
control line and, if positive, a second line appeared on the test field. The test is
based on a combination of protein A-colloidal gold conjugate and rK39 Leish-
mania antigen to detect anti-Leishmania antibody in serum or plasma.
Negative and positive controls. Three groups of uninfected dog sera were used
as negative controls for all diagnostic tests. The sera came from (i) dogs of
various ages and breeds, which had attended a veterinary clinic in Lima, Peru
(n  17); (ii) mongrel dogs from Bele´m, Brazil (n  12); and (iii) dogs of various
ages and breeds that had attended a veterinary clinic in Cambridge, United
Kingdom (n  11). The positive standard control serum as well as nine other
high-titer-positive control sera came from dogs with confirmed L. infantum
infection (either by culture, microscopy, or xenodiagnosis) from Marajo´, Brazil
(19, 20).
Data analysis. Sensitivity, specificity, and positive, and negative predictive
values (PPV and NPV, respectively) for each diagnostic test were calculated
according to the method of Fleiss (11). The PPV of a diagnostic test is the
proportion of total positive test results that are true positives and the NPV of a
diagnostic test is the proportion of total negative results that are true negatives.
RESULTS
Table 1 summarizes the dipstick, ELISA, and PCR results
from field samples and negative and positive controls, as well
as the frequency distribution of log units of anti-Leishmania
antibody units per milliliter depending on dipstick or PCR
positivity is represented in Fig. 1. The mean antibody levels for
the three groups of negative controls were 2,562 (standard
deviation  558 [Lima]), 1,099 (standard deviation  689
[Marajo´]), and 1,854 (standard deviation  783 [Cambridge])
U/ml. The mean number of antibody units of all negative
controls was 1,831 (standard deviation 978) U/ml; hence, the
cutoff for positivity was 4,765 U/ml (i.e., 3.68 log antibody
units/ml). The mean for positive control sera was 170,237
(standard deviation  97,281) U/ml.
None of the 40 negative control samples was positive by
ELISA or PCR (Table 1), but 10 out of 40 negative control
sera were positive by using the dipstick. Thus, the specificities
of the PCR, ELISA, and dipstick were 100, 100, and 75%,
respectively. The 10 negative control dogs that were positive by
the dipstick test came from Cambridge (n  4), Peru (n  2),
and Brazil (n  4) (mean number of antibody units per milli-
liter  1,851, standard deviation  1,230). All 10 positive
controls were positive by both ELISA and dipstick (i.e., 100%
sensitivity), while 8 of 10 were positive by PCR. The propor-
tions of the field samples positive by each diagnostic technique
were 53% (92 of 175), 37% (65 of 175), and 27% (47 of 175)
for dipstick, ELISA, and PCR, respectively.
To estimate the sensitivity and specificity of each test in the
field samples, the true number of infected dogs must be esti-
mated. Two approaches were used to estimate the number of
infected and uninfected field dogs. In approach 1, we used the
estimates of 100% specificity for ELISA and PCR from the
control samples (i.e., all ELISA and/or PCR positives are true
TABLE 1. Comparative diagnosis of L. infantum in dog blood
ELISA/PCR
result
No. of samples with result
Negative controlsa
(n  40)
Positive
controlsa
(RAPYD
[n  10])
Field samples
(n  175)
RAPYD RAPYD RAPYD RAPYD
ELISA/PCR 8 30 8
ELISA/PCR 6 3
ELISA/PCR 2 17 10
ELISA/PCR 10 30 39 62
a PCRs of positive and negative Marajo´ controls were carried out with sera,
not buffy coat.
VOL. 40, 2002 RAPID DETECTION OF LEISHMANIA INFANTUM IN DOGS 2353
positives) and assumed that all ELISA-negative, PCR-negative
samples were true negatives (i.e., all 39 RAPYD-positive, but
ELISA-negative, PCR-negative samples were false positives).
Approach 1 gives an estimated 74 positives and 101 negatives.
In approach 2, we again used the estimated 100% specificity
for ELISA and PCR, but also uded the estimated 75% dipstick
specificity. Thus, only 21 (62/3) of the 39 RAPYD-positive,
ELISA-negative, PCR-negative samples are false positives,
and 18 are true positives. Approach 2 gives a total of 92
positives and 83 negatives. Table 2 summarizes the sensitivity,
specificity, PPV, and NPV of each test by each approach. With
approach 1, the sensitivity and specificity of the dipstick test
were 72 and 61%, respectively; approach 2 increases the esti-
mated sensitivity to 77%. The respective sensitivities of ELISA
and PCR were 88 and 64% by approach 1 and 71 and 51% by
approach 2 (Table 2).
DISCUSSION
To our knowledge, this is the first study to use a dipstick test
to detect Leishmania infection in dogs. Our study indicates that
the dipstick test has a comparable sensitivity to ELISA, but
that its specificity is very low (61 to 75%). Thus, use of the
dipstick tests would lead to a high proportion of dogs being
misdiagnosed as false positives (up to 39 out of 92 positive field
samples; Table 1). The reason why this was the case is un-
known, but it could include test cross-reactivity to some factor
present in dog blood, because tested rK39 dipsticks were highly
specific when tested on blood from kala-azar patients. Previous
studies using the rK39-ELISA assay reported responsiveness
to rK39 in (i) 2 of 33 Chinese toxoplasmosis patients (although
the authors reported that the two responsive patients may have
had subclinical ZVL) (24), (ii) 2 of 61 healthy Sudanese con-
trols from a region of endemicity (29), (iii) 1 of 10 Turkish
malaria patients (17), and (iv) 6 of 83 Turkish cutaneous leish-
maniasis patients (17). The rK39 antigen is not known to cross-
react with Leishmania braziliensis or T. cruzi (4, 7, 8, 18). Also,
rK39 responsiveness appears to be restricted to active kala-
azar infections, as opposed to asymptomatic, self-healing,
cured, or treatment-resistant patients (4, 14, 24) or dogs (22,
23), although other studies failed to show such an association
(29, 30).
Five reported studies used an rK39-ELISA to detect Leish-
mania infection in dogs (4, 17, 22, 23, 28). The rK39-ELISA
was 100% sensitive in 90 parasitologically confirmed, high-
antibody-titer dogs in Brazil (4) and in 37 parasitologically
confirmed dogs in Venezuela (negative controls not included
in either study) (28). In a Turkish study, 18 of 494 dogs were
positive by rK39-ELISA; sensitivity and specificity were re-
ported to be 93% and 100%, respectively (17). In a large
epidemiological survey in Italy, rK39-ELISA sensitivity and
specificity were 97 and 99%, respectively (23). Finally, in a
Moroccan study, the rK39-ELISA was 100% sensitive in de-
tecting 11 parasitologically confirmed, clinically symptomatic
FIG. 1. Frequency distribution of anti-Leishmania antibody (log units per milliliter) in field samples tested.
TABLE 2. Sensitivity, specificity, PPV, and NPV for
the diagnostic tests used in this studya
Approach % PPV % NPV % Sensitivity % Specificity
PCR
1 100 (47/47) 79 (101/128) 64 (47/74) 100 (101/101)
2 100 (47/47) 65 (83/128) 51 (47/92) 100 (83/83)
ELISA
1 100 (65/65) 92 (101/110) 88 (65/74) 100 (101/101)
2 100 (65/65) 75 (83/110) 71 (65/92) 100 (83/83)
RAPYDTEST
1 58 (53/92) 75 (62/83) 72 (53/74) 61 (62/101)
2 77 (71/92) 75 (62/83) 77 (71/92) 75 (62/83)
a See the text for specific details of the approaches used to estimate the PPV,
NPV, sensitivity, and specificity of each diagnostic test. The different assump-
tions made for each approach are in italic. Values in parentheses represent the
number with result/number tested.
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dogs, but failed to detect ZVL infection in 9 parasitologically
confirmed, clinically asymptomatic dogs (22). Variability in
dipstick performance will depend on factors such as the type of
diagnostic antigen and conjugate used. Previous experience
with malaria dipstick tests show that these tests can be highly
variable in terms of sensitivity and specificity (27). False-posi-
tive rates for malaria dipsticks can be as high as 28%, which
may, for example, be due to cross-reactivity to rheumatoid
factor (16).
A number of PCR protocols to detect L. infantum have been
developed, and PCR has been shown to be a sensitive and
highly specific technique for the detection of symptomatic or
parasitologically proven infections (2, 20, 28). Evidence sug-
gests that PCR is less sensitive in detecting asymptomatic dogs
(2, 20). The results presented here confirm this observation,
because PCR detected only 79% of ELISA-positive and 39%
of dipstick-positive field samples, with PCR positivity being
associated with ELISA antibody units (linear regression after
arc-sine transformation of data: df  39, r  0.84, P  0.001).
The sensitivity and specificity of the PCR assay depend on
several factors, including PCR primers, DNA extraction pro-
tocol, and source of biopsy material (15, 21). The advantage of
using blood (buffy coat) is that the sampling is less invasive
than bone marrow, spleen, or lymph node aspirates, and sam-
ples can be processed readily. On the other hand, the parasite
load in blood tends to be lower than those in bone marrow,
spleen, or lymph node aspirates, and blood may contain a
number of PCR inhibitors (e.g., heme) that may affect PCR
assay sensitivity.
With a conservative cutoff (i.e., mean  3 standard devia-
tions) (19, 20), ELISA was 100% sensitive in detecting culture-
positive dogs and 84% sensitive to detect parasitologically con-
firmed (PCR) field dogs. Interestingly, four of nine PCR-
positive but ELISA-negative samples were from dogs that had
recovered serologically by the time the second samples were
taken. This demonstrates that the sensitivity of a diagnostic
technique can change with the course of infection (20) and that
these dogs appear to have developed an immune response that
controls infection. The sensitivity and specificity of ELISA
depend on the type of antigen used (e.g., parasite species,
promastigotes, or amastigotes) and changes to the standard
experimental protocol (e.g., incubation time or type of micro-
titer plates used).
We conclude that research into developing a more specific
Leishmania dipstick test should be pursued, because there are
many potential advantages of such a tool with respect to other
diagnostic methods. With dipsticks, a large number of samples
can be processed quickly and with minimum effort. Compared
to microscopy, ELISA, or PCR, the technological expertise
(i.e., training of personnel) necessary to perform the dipstick
tests is minimal, as is the requirement for specialized labora-
tory equipment. Another advantage of dipstick tests is that
patients (in our case, dog owners) can see the results for
themselves, which will contribute to a better working relation-
ship between local communities and people carrying out the
surveys and would increase compliance rates. From an epide-
miological point of view, a dipstick test allows interventions to
be implemented in situ. The outcome should be to significantly
reduce the mean duration of infectiousness of dogs that have
become infected, thereby significantly enhancing the impact of
the intervention on the basic reproductive number, Ro (10).
Immunochromatographic dipstick tests are comparatively
expensive, but considering the data presented above, a sensi-
tive and specific dipstick test could provide very cost-effective
alternatives to currently available diagnostic tests, especially
when used in mass-screening surveys.
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